Clinical Trial Update: A Study Observing the Long-term, Effectiveness and Safety of Odevixibat (Bylvay) in Patients With Alagille Syndrome (ALGS) Who Are Receiving Ongoing Treatment

View source ↗

Summary

This clinical trial update notes the long-term effectiveness and safety assessment of odevixibat (Bylvay) in patients with Alagille syndrome who are receiving o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alagille Syndrome

Drugs mentioned

• BYLVAY (odevixibat)

Snippet

Sponsor: Ipsen | Conditions: Alagille Syndrome | Status: RECRUITING